Day 1

ABSORB II: Seguimento de 2 anos não demonstrou superioridade do scaffold bioabsorvível eluidor de everolimus vs stent metálico eluidor everolimus em pacientes com doença arterial coronariana

solaci
solaci
549
0
2_bernard_chevalier

Bernard R. Chevalier

Previous article
TAVI in patients older than 90: similar outcomes to those obtained in younger patients
Next article
ESTUDO BIOSOLVE II: Estudo first-in-man demonstra melhores resultados com segunda geração de stent metálico eluidor de sirolimus bioabsorvível (DREAMS 2G) em comparação com BIOSOLVE I
solaci
solaci

More articles by this author

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

UNICORN Technique to Prevent Coronary Obstruction During TAVI: Initial Results From a Multicenter Study

Dr. Juan Manuel Pérez - 0
Coronary obstruction is an uncommon but potentially catastrophic complication of transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, TAV-in-TAV interventions, or in patients...

Supera vs. Eluvia at 3 Years in Severely Calcified Femoropopliteal Lesions

Dr. Juan Manuel Pérez - 0
Severe calcification remains one of the main predictors of restenosis and the need for repeat revascularization following endovascular treatment of femoropopliteal disease. In this...

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Dr. Juan Manuel Pérez - 0
Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...